T-1105 in A1 PKC-412A and CGP 41251

PKC-412A and CGP 41251

is a P2X3 receptor antagonist

InChi: InChI=1S/C26H23F4N9O

MC-VC-PABC-SP 141 is a drug-linker conjugate for ADC with potent antitumor activity by using SP 141 (a potent MDM2 inhibitor)

It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms

T-1105 in A1 PKC-412A and CGP 41251T 1105, a novel broad spectrum viral polymerase inhibitor, structural analogue of T 705, inhibits the polymerases of RNA viruses after being converted to ribonucleoside triphosphate (RTP) metabolite. T 1105 has antiviral activity against various RNA viruses, including Zika virus (ZIKV), influenza virus, arenaviruses, bunyaviruses, West Nile virus (WNV), yellow fever virus (YFV), and foot and mouth disease virus (FMDV). T 1105 can be formed by